Objectives: Formulation of MLC SMEDDS and application to preparation of meloxicam 7.5 mg tablets with high dissolution compared to the reference product - Mobic® 7.5 mg. Methods: MLC SMEDDS were formulated by using phase diagram, then solidification and application to preparation of meloxicam 7.5 mg tablets with high dissolution compared to Mobic® 7.5 mg tablets.